Human polynucleotides and polypeptides encoded thereby
CA 2421576 A1 · Owner: Macdougall, John R. · Inventors: Shenoy, Suresh; Gorman, Linda; Macdougall, John R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed herein are nucleic acid sequences that encode Wnt zinc transporter, mitsugumin29, slit-3 LRR/GPCR, major histocompatibility complex enhancer protein MAD3, interleukin 9, 5-hydroxytryptamine receptor and thioredoxin , related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants mutants, or fragments of the , aforementioned polypeptide polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis treatment, and prevention of disorders involving any one of these novel human nucleic acids and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 17, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 17, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 17, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.